D14122 Phase II study of Pre-emptive OsciLLation of ER activitY levels through alternation of estradiol/anti-estrogen therapies prior to disease progression in ER+/HER2- metastatic breast cancer (POLLY)

IRB15-095
Cancer - Breast, Cancer
Grace Makari-Judson, MD

D'Amour Center for Cancer Care

3350 Main Street
Springfield, MA 01199

In this study, patients will alternate anti-cancer drugs without waiting for the cancer to get worse.  We want to see if alternating medicines will lengthen the time it takes for the cancer to get worse, and to prevent the cancer from getting worse
ER+/HER2-, Metastatic Breast Cancer
Rae Lynn Defeo
413-794-0255